We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Seegene

Seegene, Inc. is a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics for inf... read more Featured Products: More products

Download Mobile App




Medlab Middle East to Reveal Latest Innovations and Technologies in Mobile Labs for COVID-19 Testing

By LabMedica International staff writers
Posted on 14 Jan 2022

The latest technology and innovation in the global fight against COVID-19 and beyond will be on show at the next edition of Medlab Middle East organized by Informa Markets (London, UK), when it returns to the Dubai World Trade Centre from 24-27 January 2022 with mobile molecular testing and diagnosis stations, or ‘laboratories on wheels’, from companies such as Seegene, Inc. More...

(Seoul, Korea) taking centre stage.

Mobile laboratories offer testing and diagnosis on the go, with many having the capacity to conduct upwards of 7,500 tests per day and a turnaround time of just 3.5 hours. The tests cover a variety of pathogens and offer a streamlined, automated workflow, from pre-extraction to data analysis. Typically, a mobile lab features an equipment room and an extraction room and laboratory. Technology within the station allows for automated testing with little supervision while incorporating other equipment such as RT-PCR reagents, consumables, and technical support for diagnostic testing. The other benefit mobile laboratories offer is they can be transported via ship or lorry to almost any place in the world and are fully operational within days of arrival. They can then conduct mass testing in schools, airports, or communities impacted by the pandemic.

Seegene will be among the companies to showcase its latest innovative products concerning COVID-19 testing during the event. The company recently partnered with Abu Dhabi’s G42 Healthcare to offer mobile laboratory stations across the Middle East and North Africa (MENA) region. In addition to highlighting the latest technology in the fight against COVID-19, the event will also see the return of the Medlab Middle East Congress COVID-19 Updates track. A number of global experts from USA, Europe and GCC will highlight further developments on COVID-19 vaccines and updates on the management of COVID-19 variants. The event will take place under strict protocols and enhanced measures that include 35 guidelines covering all aspects of cleaning and hygiene, social distancing measures, and the use of PPE, screening, and a track and trace in conjunction with local authorities.

“Mobile labs offers the most innovative mobile molecule diagnostic, testing and laboratory services and have had a major impact on the support they have been able to provide the healthcare community in combating COVID-19 infections,” said Tom Coleman, Exhibition Director for Informa Markets who are organizing Medlab Middle East. “As a result of COVID-19, we have seen the laboratory industry fast track a range of new cutting-edge technologies that have had a remarkable impact in the fight against the pandemic. Seegene’s Mobile Station is a prime example of accelerating transformation within the laboratory market, something we will be showcasing during Medlab Middle East in January.”

Related Links:
Seegene, Inc. 
Informa Markets


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Immunoassay Analyzer
Procise DX
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
image Credit: iStock

Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer

Outcomes after resection for lung squamous cell carcinoma (SqCC) vary substantially, and the uneven benefit of adjuvant chemotherapy complicates postsurgical treatment decisions. Pathologic markers that... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.